SCHEMBL2283523

SCHEMBL2283523

C=CCOc1cc(OC)c(C(=O)/C=C/c2cccc(OC)c2)c(OCC=C)c1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCG2 Q9UNQ0 4/20 0.64
FLT3 P36888 1/20 0.59
TXNRD1 Q16881 1/20 0.54
TXNRD3 Q86VQ6 1/20 0.54
TXNRD2 Q9NNW7 1/20 0.54
ABCB1 P08183 1/20 0.54
TP53 P04637 2/20 0.53
MDM2 Q00987 1/20 0.53
CYP3A4 P08684 3/20 0.53
CYP1A2 P05177 2/20 0.53
CYP2D6 P10635 2/20 0.53
CYP2C9 P11712 1/20 0.53
CYP2C19 P33261 1/20 0.53
MAOB P27338 3/20 0.52
BCHE P06276 1/20 0.52
MAPT P10636 2/20 0.51
KMT2A Q03164 2/20 0.51
ATM Q13315 1/20 0.51
HSD17B10 Q99714 1/20 0.51
KDM4E B2RXH2 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2283527 1.00 ABCG2 (0.64) ABCG2FLT3TXNRD1TXNRD3TXNRD2
SCHEMBL1938570 0.90 MAPT (0.60) ABCG2FLT3TXNRD1TXNRD3TXNRD2
SCHEMBL1938567 0.90 MAPT (0.60) ABCG2FLT3TXNRD1TXNRD3TXNRD2
SCHEMBL2284259 0.88 FLT3 (0.73) ABCG2FLT3ABCB1TP53MDM2
SCHEMBL2284249 0.88 FLT3 (0.73) ABCG2FLT3ABCB1TP53MDM2
SCHEMBL2282041 0.86 KDM4E (0.66) ABCG2FLT3TXNRD1TXNRD3TXNRD2
SCHEMBL2282048 0.86 KDM4E (0.66) ABCG2FLT3TXNRD1TXNRD3TXNRD2
SCHEMBL30383135 0.86 KDM4E (0.66) ABCG2FLT3TXNRD1TXNRD3TXNRD2
SCHEMBL12375190 0.85 ABCG2 (0.70) ABCG2FLT3TP53MDM2CYP3A4
SCHEMBL2288977 0.84 FLT3 (0.58) ABCG2FLT3TP53MDM2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9061984-B2 Compounds related to chalcones and benzothienopyrimidines, their synthesis, and uses to treat diseases UNIVERSITY OF LOUISVILLE RESEARCH FOUNDATION, INC. (US) 2015-06-23 US disclosed
US-9061984-B2 Compounds related to chalcones and benzothienopyrimidines, their synthesis, and uses to treat diseases UNIVERSITY OF LOUISVILLE RESEARCH FOUNDATION, INC. (US) 2015-06-23 US disclosed
US-9061984-B2 Compounds related to chalcones and benzothienopyrimidines, their synthesis, and uses to treat diseases UNIVERSITY OF LOUISVILLE RESEARCH FOUNDATION, INC. (US) 2015-06-23 US disclosed
US-20110190325-A1 COMPOUNDS, THEIR SYNTHESES, AND THIER USES THE JOHNS HOPKINS UNIVERSITY 2011-08-04 US disclosed
US-20110190325-A1 COMPOUNDS, THEIR SYNTHESES, AND THIER USES THE JOHNS HOPKINS UNIVERSITY 2011-08-04 US disclosed
US-20110190325-A1 COMPOUNDS, THEIR SYNTHESES, AND THIER USES THE JOHNS HOPKINS UNIVERSITY 2011-08-04 US disclosed
WO-2010019861-A1 COMPOUNDS, THEIR SYNTHESES, AND THEIR USES UNIVERSITY OF LOUISVILLE RESEARCH FOUNDATION, INC. (US) 2010-02-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110190325-A1 COMPOUNDS, THEIR SYNTHESES, AND THIER USES TERT, TYMS, NISCH ABCG2 1032/4885FLT3 213/4885TXNRD1 1179/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.